ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,486Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 1844

$936K Total Retail Price of All Prescriptions

Rank: 64 out of 1844

589 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 589 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 589 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,638 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
PRAVASTATIN SODIUM 1,010 912 1 10
AMLODIPINE BESYLATE 543 483 2 6
LEVOTHYROXINE SODIUM 500 445 3 1
LISINOPRIL 440 378 4 4
OMEPRAZOLE 387 338 5 5
METOPROLOL SUCCINATE 321 286 6 14
TRAMADOL HCL 296 242 7 18
METOPROLOL TARTRATE 276 266 8 11
ATORVASTATIN CALCIUM 258 202 9 12
AMLODIPINE BESYLATE-BENAZEPRIL 256 236 10 80
METFORMIN HCL 227 191 11 8
MELOXICAM 214 199 12 28
LOSARTAN POTASSIUM 213 208 13 24
CITALOPRAM HBR 208 156 14 19
HYDROCODONE-ACETAMINOPHEN 208 159 S3 14 2
NEXIUM 196 164 16 31
FUROSEMIDE 193 188 17 7
GABAPENTIN 167 126 18 15
ZOLPIDEM TARTRATE 165 149 19 23
WARFARIN SODIUM 157 112 20 13
FENOFIBRATE 144 129 21 71
ATENOLOL 138 122 22 17
CARVEDILOL 138 128 22 22
LOSARTAN-HYDROCHLOROTHIAZIDE 132 112 24 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 124 25 20
RANITIDINE HCL 119 98 26 38
BENAZEPRIL HCL 116 116 27 75
TAMSULOSIN HCL 109 109 28 27
CLOPIDOGREL 98 91 29 34
SPIRONOLACTONE 95 90 30 60
POTASSIUM CHLORIDE 93 76 31 16
AMOXICILLIN 92 80 32 101
DIOVAN 89 88 33 58
TRICOR 88 66 34 109
PREDNISONE 88 83 34 40
BENICAR 84 81 36 218
GLIMEPIRIDE 82 59 37 35
BENICAR HCT 78 72 38 244
PANTOPRAZOLE SODIUM 77 62 39 32
SERTRALINE HCL 76 65 40 21
PEN NEEDLE 75 42 41 135
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 56 42 73
SPIRONOLACTONE-HCTZ 72 69 43 203
SYNTHROID 72 58 43 55
HYDROCHLOROTHIAZIDE 71 71 45 9
AZITHROMYCIN 70 66 46 37
LOVASTATIN 66 66 47 44
NABUMETONE 66 64 47 158
EXFORGE 66 51 47 227
PLAVIX 65 61 50 61
ALLOPURINOL 65 53 50 29
PRAMIPEXOLE DIHYDROCHLORIDE 65 56 50 193
PAROXETINE HCL 64 64 53 68
CYCLOBENZAPRINE HCL 63 62 R 54 53
AMITRIPTYLINE HCL 61 56 R 55 72
LEVEMIR FLEXPEN 60 50 56 166
CYMBALTA 59 46 57 36
DONEPEZIL HCL 59 59 57 26
LOVAZA 56 32 59 138
ESCITALOPRAM OXALATE 56 56 59 52
LIPITOR 54 52 61 159
NOVOLOG FLEXPEN 53 34 62 163
ADVAIR DISKUS 53 51 62 51
COMBIVENT 51 48 64 131
SIMVASTATIN 50 50 65 3
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.